Quaker Chemical (KWR) has drawn fresh attention after opening a new manufacturing facility in Zhangjiagang and expanding its Shanghai laboratory, moves aimed at supporting growing Asia Pacific demand and broadening local production.

Alongside the Zhangjiagang and Shanghai expansions, Quaker Chemical has also been added to the Russell 2000 Dynamic Index. The stock’s recent 30 day share price return of 13.15% and 1 year total shareholder return of 32.76% sit against weaker 3 and 5 year total shareholder returns, suggesting momentum has picked up recently after a tougher longer term stretch.

If this shift in sentiment has you looking beyond Quaker Chemical, it could be a good time to scan other materials and industrial suppliers with the help of 20 top founder-led companies

Quaker Chemical now trades close to analyst targets and appears undervalued on some intrinsic measures. However, recent gains have been sharp, so is there still a buying opportunity here, or is the market already pricing in future growth?

Most Popular Narrative: 5.1% Undervalued

Quaker Chemical's most followed narrative pegs fair value around $169.86 per share, slightly above the last close of $161.25, and frames that gap around future earnings power rather than short term price momentum.

Significant capital investment (e.g., new China facility, Thailand plant upgrade, enhanced manufacturing capabilities) and integration of the Dipsol acquisition expand Quaker's footprint in high-growth Asia/Pacific regions. This positions the company to capitalize on manufacturing reshoring, structural growth in Asian auto/e-mobility markets, and local-for-local supply strategies, which are cited as drivers of future revenue and gross margin expansion.

Curious what has to happen for Quaker Chemical to match that fair value? The narrative leans on faster earnings growth, richer margins, and a very specific profit multiple. The assumptions are bold. The earnings step up is large. The crux is how those moving parts fit together over the next few years.

Result: Fair Value of $169.86 (UNDERVALUED)

However, the Quaker Chemical narrative still leans heavily on sharp margin expansion and higher earnings, which could be challenged if raw material costs or EMEA weakness persist.

Another View: Quaker Chemical On Sales Based Valuation

The SWS DCF model suggests Quaker Chemical is trading well below its estimated future cash flow value, with the stock at $161.25 against a model value of $288.21, which is framed as undervalued. That is a very different message compared with pricing the stock off analyst earnings multiples.

For investors, the key question is which lens to trust more: a cash flow model that points to a large gap, or market based multiples that sit much closer to current prices.

Next Steps

If this mix of fresh momentum and competing valuation stories around Quaker Chemical has you curious, it makes sense to look at the data now and decide where you stand, starting with 2 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Quaker Chemical?

If Quaker Chemical has sharpened your interest, now is the moment to widen your watchlist with other stocks that fit clear, data backed themes using the Simply Wall St Screener.

• Target reliable income streams by scanning companies that stand out as 8 dividend fortresses so you can focus on payouts with substance, not just headlines.
• Spot quality at a discount by reviewing the 41 high quality undervalued stocks and see which stocks currently pair solid fundamentals with prices that lag underlying metrics.
• Prioritise resilience by checking the 73 resilient stocks with low risk scores and see which companies our models flag for more robust balance sheets and lower overall risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.